The Rise and Fall of Oral Ketoconazole

Journal of Cutaneous Medicine and Surgery
Aditya K Gupta, Danika C A Lyons

Abstract

Ketoconazole was the first broad-spectrum oral antifungal agent available to treat systemic and superficial mycoses. Evidence of hepatotoxicity associated with its use emerged within the first few years of its approval. Growing evidence of serious side effects including endocrine dysregulation, several drug interactions, and death led to the review of oral ketoconazole in 2011. This article chronicles the use of oral ketoconazole from its introduction to its near replacement in medicine. Due to its hepatotoxic side effects, oral ketoconazole was withdrawn from the European and Australian markets in 2013. The United States imposed strict relabeling requirements and restrictions for prescription, with Canada issuing a risk communication echoing these concerns. Today, oral ketoconazole is only indicated for endemic mycoses, where alternatives are not available or feasible. Meanwhile, topical ketoconazole is effective, safe, and widely prescribed for superficial mycoses, particularly as the first-line treatment for tinea versicolor.

References

May 15, 1979·Experientia·D ThienpontP A Janssen
Aug 1, 1978·The Journal of Infectious Diseases·D DixonT M Kerkering
Jul 27, 1985·Lancet·A P D'MelloT R Bates
Apr 1, 1988·Clinical Microbiology Reviews·R A Fromtling
Feb 14, 1987·British Medical Journal·G Lake-BakaarS Sherlock
Jan 1, 1988·Clinical Pharmacokinetics·T K Daneshmend, D W Warnock
Dec 1, 1987·Antimicrobial Agents and Chemotherapy·A M SugarD A Stevens
Jan 1, 1986·Journal of Hepatology·B H StrickerV J Desmet
Nov 1, 1986·The Journal of Clinical Endocrinology and Metabolism·J RajferD J Handelsman
Oct 1, 1968·Diseases of the Chest·J D Dutcher
Jan 24, 1983·The American Journal of Medicine·P A Janssen, J E Symoens
Jan 1, 1980·The Journal of Antimicrobial Chemotherapy·F C OddsE H Ball
Jun 1, 1980·Antimicrobial Agents and Chemotherapy·H Van den BosscheJ M van Cutsem
Jul 1, 1980·Reviews of Infectious Diseases·J P Utz
Dec 1, 1980·Annals of Internal Medicine·J R GraybillA L Murphy
Jun 1, 1981·Antimicrobial Agents and Chemotherapy·R DeFeliceJ N Galgiani
Sep 1, 1982·Annals of Internal Medicine·A PontD A Stevens
Jan 24, 1983·The American Journal of Medicine·D A StevensA M Sugar
May 1, 1983·The Journal of Clinical Investigation·D S LooseD Feldman
Oct 1, 1983·The Journal of Clinical Endocrinology and Metabolism·R J SantenR DeCoster
Aug 1, 1995·Antimicrobial Agents and Chemotherapy·T W ChinI W Fong
Feb 1, 1994·Antimicrobial Agents and Chemotherapy·J D HoescheleP L Carver
May 1, 1994·Journal of the American Academy of Dermatology·A K GuptaN H Shear
Jan 1, 1997·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·R N ChienY F Liaw
Nov 5, 1999·Clinical Pharmacology and Therapeutics·B D HermanM T Brown
Dec 14, 1999·British Journal of Clinical Pharmacology·L A García RodríguezB H Stricker
Oct 7, 2009·Expert Review of Anti-infective Therapy·Maria Teresa FeraAngelina De Sarro
Oct 17, 2012·Clinics in Dermatology·Oliverio WelshAlexandro Bonifaz
Nov 1, 2013·Anais Brasileiros De Dermatologia·Silvio Alencar Marques
Feb 22, 2014·Acta Dermato-venereologica·Marianne HaldDitte Marie L Saunte
May 3, 2014·Expert Opinion on Drug Safety·Jerzy Z Nowak
Jul 6, 2014·Expert Opinion on Pharmacotherapy·Aditya K Gupta, Danika C A Lyons
Sep 13, 2014·Journal of Clinical Pharmacology·H Karl Greenblatt, David J Greenblatt

❮ Previous
Next ❯

Citations

Feb 24, 2017·American Journal of Respiratory Cell and Molecular Biology·Jasmijn A SchrumpfPieter S Hiemstra
Aug 19, 2017·International Journal of Toxicology·Qiang ShiWilliam F Salminen
Jan 23, 2019·The Journal of Dermatological Treatment·Franchesca D ChoiNatasha Atanaskova Mesinkovska
Jul 10, 2019·Journal of the European Academy of Dermatology and Venereology : JEADV·E H TaudorfD M L Saunte
Feb 6, 2020·Journal of the European Academy of Dermatology and Venereology : JEADV·C VlachosD M Saunte
Nov 5, 2019·Frontiers in Pharmacology·Tabea Osthues, Marco Sisignano
May 10, 2019·Frontiers in Microbiology·Jingxiang ZhangYuanying Jiang
Dec 5, 2019·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Wilfried RozhonBrigitte Poppenberger
Jan 4, 2017·Pediatrics in Review·Aditya K GuptaSheila Fallon Friedlander
Jul 19, 2019·BMC Infectious Diseases·Hang FangDaozhang Cai
Oct 21, 2020·The Journal of Dermatological Treatment·Suraj MuddasaniAlan B Fleischer
May 13, 2021·F1000Research·Priscila Costa AlbuquerqueRodrigo Almeida-Paes
Jan 28, 2020·Molecular Pharmaceutics·Flavia MartinIoana Bâldea

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Related Papers

International Journal of Dermatology
J B SadequeM Kamal
The Western Journal of Medicine
P H Jacobs
International Journal of Dermatology
D R Goodless
© 2021 Meta ULC. All rights reserved